Skip to main content

Advertisement

SpringerLink
Log in

Development and Evaluation of a Novel Drug in Adhesive Transdermal System of Levodopa and Carbidopa

  • Research Article
  • Published:
Journal of Pharmaceutical Innovation Aims and scope Submit manuscript

Abstract

Purpose

Administration of levodopa along with carbidopa increases the availability of dopamine in the mid-brain, and this combination thereby is used in the treatment of parkinsonism. However, concomitant delivery of levodopa with carbidopa in oral therapy is limited by several issues and an alternative route would be advantageous. The current study assesses the feasibility of co-administration of levodopa and carbidopa through skin using a drug in adhesive transdermal system.

Methods

Drug in adhesive transdermal system containing levodopa (5 % w/w) and carbidopa (2.5 % w/w) (1 cm2 area) was fabricated and assessed for in vitro drug release, ex vivo permeation, and in vivo pharmacokinetics in rat model.

Results

In vitro dissolution profiles indicated a biphasic pattern with an initial burst effect for both levodopa and carbidopa, although the drug release rate was relatively higher for carbidopa. Ex vivo permeation studies showed higher steady-state flux for levodopa (53.77 ± 6.94 μg/cm2/h) and carbidopa (23.81 ± 4.06 μg/cm2/h). In vivo studies revealed that the concomitant transdermal delivery of levodopa with carbidopa significantly changed the pharmacokinetic parameters of levodopa.

Conclusions

Given the promising results, this study concludes that the transdermal delivery route could be a feasible alternative to oral therapy for the successful delivery of levodopa in Parkinson’s disorder.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Fig. 1
Fig. 2
Fig. 3
Fig. 4

Similar content being viewed by others

References

  1. World Health Organisation. Neurology Atlas References. 2004.

  2. Prakash KM, Tan EK. Development of Parkinson’s disease biomarkers. Expert Rev Neurother. 2010;10:1811–25.

    Article  CAS  PubMed  Google Scholar 

  3. Fernandez HH. Updates in the medical management of Parkinson disease. Clevel Clin J Med. 2012;79:28–35.

    Article  Google Scholar 

  4. Da Prada M, Kettler R, Zürcher G, Schaffner R, Haefely WE. Inhibition of decarboxylase and levels of dopa and 3-O-methyldopa: a comparative study of benserazide versus carbidopa in rodents and of Madopar standard versus Madopar HBS in volunteers. Eur Neurol. 1987;27:9–20.

    Article  PubMed  Google Scholar 

  5. Kao HD, Traboulsi A, Itoh S, Hussain A. Enhancement of the systemic and CNS specific delivery of L-dopa by the nasal administration of its water soluble prodrugs. Pharm Res. 2000;17:978–84.

    Article  CAS  PubMed  Google Scholar 

  6. Howe M. Current treatments for restless leg syndrome, http://www.freece.com/Files/Classroom/ProgramSlides/d3afb991-2c3a-4d66-b335-ae42a854398c/RLS%20Homestudy.pdf. Accessed 20 Nov 2013.

  7. Olanow CW, Stern MB, Sethi K. The scientific and clinical basis for the treatment of Parkinson disease (2009). Neurology. 2009;72:S1–136.

    Article  PubMed  Google Scholar 

  8. Mao Z, Hsu A, Gupta S, Modi NB. Population pharmacodynamics of IPX066: an oral extended-release capsule formulation of carbidopa-levodopa, and immediate-release carbidopa-levodopa in patients with advanced Parkinson’s disease. J Clin Pharmacol. 2013;53:523–31.

    Article  CAS  PubMed Central  PubMed  Google Scholar 

  9. Lundqvist C. Continuous levodopa for advanced Parkinson’s disease. Neuropsychiatr Dis Treat. 2007;3:335–48.

    CAS  PubMed Central  PubMed  Google Scholar 

  10. Deleu D, Ebinger G, Michotte Y. Clinical and pharmacokinetic comparison of oral and duodenal delivery of levodopa/carbidopa in patients with Parkinson’s disease with a fluctuating response to levodopa. Eur J ClinPharmacol. 1991;41:453–8.

    Article  CAS  Google Scholar 

  11. Prausnitz MR, Langer R. Transdermal drug delivery. Nat Biotechnol. 2008;26:1261–8.

    Article  CAS  PubMed Central  PubMed  Google Scholar 

  12. Nair A, Vyas H, Shah J, Kumar A. Effect of permeation enhancers on the iontophoretic transport of metoprolol tartrate and the drug retention in skin. Drug Deliv. 2011;18:19–25.

    Article  CAS  PubMed  Google Scholar 

  13. Langer R. Transdermal drug delivery: past progress, current status, and future prospects. Adv Drug Deliv Rev. 2004;56:557–8.

    Article  CAS  PubMed  Google Scholar 

  14. Doshi AS, Upadhyay KJ, Mehta TN, Nanda N. Development and application of a high-performance liquid chromatographic method for the determination of in vitro drug release of levodopa, carbidopa, and entacapone from a tablet formulation. J AOAC Int. 2009;92:394–403.

    CAS  PubMed  Google Scholar 

  15. Nair AB, Vyas H, Kumar A. Controlled release matrix uncoated tablets of enalapril maleate using HPMC alone. J Basic Clin Pharm. 2010;1:71–5.

    CAS  PubMed Central  PubMed  Google Scholar 

  16. Nair AB, Kaushik A, Attimarad M, Al-Dhubiab BE. Enhanced oral bioavailability of calcium using bovine serum albumin microspheres. Drug Deliv. 2012;19:277–85.

    Article  CAS  PubMed  Google Scholar 

  17. Nair AB, Singh K, Al-Dhubiab BE, Attimarad M, Harsha S, Alhaider IA. Skin uptake and clearance of ciclopirox following topical application. Biopharm Drug Dispos. 2013;34:540–9.

    Article  CAS  PubMed  Google Scholar 

  18. Nair AB, Vaka SR, Gupta S, Repka MA, Murthy SN. In vitro and in vivo evaluation of a hydrogel-based prototype transdermal patch system of alfuzosin hydrochloride. Pharm Dev Technol. 2012;17:158–63.

    Article  CAS  PubMed  Google Scholar 

  19. Nair A, Reddy C, Jacob S. Delivery of a classical antihypertensive agent through the skin by chemical enhancers and iontophoresis. Skin Res Technol. 2009;15:187–94.

    Article  PubMed  Google Scholar 

  20. Pfeiffer RF. Potential of transdermal drug delivery in Parkinson’s disease. Drugs Aging. 2010;19:561–70.

    Article  Google Scholar 

  21. Ngwuluka N, Pillay V, Du Toit LC, Ndesendo V, Choonara Y, Modi G, et al. Levodopa delivery systems: advancements in delivery of the gold standard. Expert Opin Drug Deliv. 2010;7:203–24.

    Article  CAS  PubMed  Google Scholar 

  22. Lee KE, Choi YJ, Oh BR, Chun IK, Gwak HS. Formulation and in vitro/in vivo evaluation of levodopa transdermal delivery systems. Int J Pharm. 2013;456:432–6.

    Article  CAS  PubMed  Google Scholar 

  23. Anroop B, Ghosh B, Parcha V, Khanam J. Transdermal delivery of atenolol: effect of prodrugs and iontophoresis. Curr Drug Deliv. 2009;6:280–90.

    Article  CAS  PubMed  Google Scholar 

  24. Ren C, Fang L, Ling L, Wang Q, Liu S, Zhao L, et al. Design and in vivo evaluation of an indapamide transdermal patch. Int J Pharm. 2009;370:129–35.

    Article  CAS  PubMed  Google Scholar 

  25. Jain P, Banga AK. Inhibition of crystallization in drug-in-adhesive-type transdermal patches. Int J Pharm. 2010;394:68–74.

    Article  CAS  PubMed  Google Scholar 

  26. Minghetti P, Cilurzo F, Pagani S, Casiraghi A, Assandri R, Montanari L. Formulation study of oxybutynin patches. Pharm Dev Technol. 2007;2:239–46.

    Article  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Department of Pharmaceutical Sciences, College of Clinical Pharmacy, King Faisal University, P.O. 400, Al-Ahsa, 31982, Kingdom of Saudi Arabia

    Anroop B. Nair & Bandar E. Al-Dhubiab

  2. Swift School of Pharmacy, SGOC, Village Ghaggar Sarai, Rajpura, Panjab, India

    Rachna Kumria

  3. M.M. College of Pharmacy, MM University, Mullana, Ambala, India

    Sumeet Gupta

Authors
  1. Anroop B. Nair
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Rachna Kumria
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Sumeet Gupta
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. Bandar E. Al-Dhubiab
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Anroop B. Nair.

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Nair, A.B., Kumria, R., Gupta, S. et al. Development and Evaluation of a Novel Drug in Adhesive Transdermal System of Levodopa and Carbidopa. J Pharm Innov 9, 302–308 (2014). https://doi.org/10.1007/s12247-014-9195-0

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s12247-014-9195-0

Keywords

Search

Navigation